Bryant Harbourne

Bryant Harbourne is a seasoned scientist with extensive experience in the field of antibody therapeutics and laboratory research. Currently serving as a Scientist at Abdera Therapeutics since December 2022, Bryant previously worked at Zymeworks Inc., where roles included Senior Research Associate focused on multispecific antibody therapeutics and various positions within the Exploratory Research Unit. Prior to Zymeworks, Bryant held multiple roles at BC Cancer Agency from 2011 to November 2018, including Research Assistant II/Lab Manager and Laboratory Technician. Bryant holds a Master's Degree in Pathology and Laboratory Medicine/Cancer from The University of British Columbia and a Bachelor's Degree with a specialization in Immunology and Infection from the University of Alberta.